Global Prescription Drugs Market Research Report 2019
Table of Contents
Executive Summary
1 Prescription Drugs Market Overview
- 1.1 Product Overview and Scope of Prescription Drugs
- 1.2 Prescription Drugs Segment by Type
- 1.2.1 Global Prescription Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Brand Drugs
- 1.2.3 Generic Drug
- 1.3 Prescription Drugs Segment by Application
- 1.3.1 Prescription Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Global Prescription Drugs Market by Region
- 1.4.1 Global Prescription Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Prescription Drugs Market Size
- 1.5.1 Global Prescription Drugs Revenue (2014-2025)
- 1.5.2 Global Prescription Drugs Production (2014-2025)
2 Global Prescription Drugs Market Competition by Manufacturers
- 2.1 Global Prescription Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Prescription Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Prescription Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Prescription Drugs Production Sites, Area Served, Product Types
- 2.5 Prescription Drugs Market Competitive Situation and Trends
- 2.5.1 Prescription Drugs Market Concentration Rate
- 2.5.2 Prescription Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Prescription Drugs Production Market Share by Regions
- 3.1 Global Prescription Drugs Production Market Share by Regions
- 3.2 Global Prescription Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Prescription Drugs Production
- 3.4.1 North America Prescription Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Prescription Drugs Production
- 3.5.1 Europe Prescription Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Prescription Drugs Production (2014-2019)
- 3.6.1 China Prescription Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Prescription Drugs Production (2014-2019)
- 3.7.1 Japan Prescription Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Prescription Drugs Consumption by Regions
- 4.1 Global Prescription Drugs Consumption by Regions
- 4.2 North America Prescription Drugs Consumption (2014-2019)
- 4.3 Europe Prescription Drugs Consumption (2014-2019)
- 4.4 China Prescription Drugs Consumption (2014-2019)
- 4.5 Japan Prescription Drugs Consumption (2014-2019)
5 Global Prescription Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Prescription Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Prescription Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Prescription Drugs Price by Type (2014-2019)
- 5.4 Global Prescription Drugs Production Growth by Type (2014-2019)
6 Global Prescription Drugs Market Analysis by Applications
- 6.1 Global Prescription Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Prescription Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Prescription Drugs Business
- 7.1 Pfizer
- 7.1.1 Pfizer Prescription Drugs Production Sites and Area Served
- 7.1.2 Prescription Drugs Product Introduction, Application and Specification
- 7.1.3 Pfizer Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Roche
- 7.2.1 Roche Prescription Drugs Production Sites and Area Served
- 7.2.2 Prescription Drugs Product Introduction, Application and Specification
- 7.2.3 Roche Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Sanofi
- 7.3.1 Sanofi Prescription Drugs Production Sites and Area Served
- 7.3.2 Prescription Drugs Product Introduction, Application and Specification
- 7.3.3 Sanofi Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Johnson & Johnson
- 7.4.1 Johnson & Johnson Prescription Drugs Production Sites and Area Served
- 7.4.2 Prescription Drugs Product Introduction, Application and Specification
- 7.4.3 Johnson & Johnson Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Merck & Co. (MSD)
- 7.5.1 Merck & Co. (MSD) Prescription Drugs Production Sites and Area Served
- 7.5.2 Prescription Drugs Product Introduction, Application and Specification
- 7.5.3 Merck & Co. (MSD) Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Novartis
- 7.6.1 Novartis Prescription Drugs Production Sites and Area Served
- 7.6.2 Prescription Drugs Product Introduction, Application and Specification
- 7.6.3 Novartis Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 AbbVie
- 7.7.1 AbbVie Prescription Drugs Production Sites and Area Served
- 7.7.2 Prescription Drugs Product Introduction, Application and Specification
- 7.7.3 AbbVie Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Gilead Sciences
- 7.8.1 Gilead Sciences Prescription Drugs Production Sites and Area Served
- 7.8.2 Prescription Drugs Product Introduction, Application and Specification
- 7.8.3 Gilead Sciences Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 GlaxoSmithKline (GSK)
- 7.9.1 GlaxoSmithKline (GSK) Prescription Drugs Production Sites and Area Served
- 7.9.2 Prescription Drugs Product Introduction, Application and Specification
- 7.9.3 GlaxoSmithKline (GSK) Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Amgen
- 7.10.1 Amgen Prescription Drugs Production Sites and Area Served
- 7.10.2 Prescription Drugs Product Introduction, Application and Specification
- 7.10.3 Amgen Prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 AstraZeneca
- 7.12 Bristol-Myers Squibb
- 7.13 Eli Lilly
- 7.14 Teva
- 7.15 Bayer
- 7.16 Novo Nordisk
- 7.17 Allergan
- 7.18 Shire
- 7.19 Boehringer Ingelheim
- 7.20 Takeda
8 Prescription Drugs Manufacturing Cost Analysis
- 8.1 Prescription Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Prescription Drugs
- 8.4 Prescription Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Prescription Drugs Distributors List
- 9.3 Prescription Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Prescription Drugs Market Forecast
- 11.1 Global Prescription Drugs Production, Revenue Forecast
- 11.1.1 Global Prescription Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Prescription Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Prescription Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Prescription Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Prescription Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Prescription Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Prescription Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Prescription Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Prescription Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Prescription Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Prescription Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Prescription Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Prescription Drugs Consumption Forecast (2019-2025)
- 11.4 Global Prescription Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Prescription Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Prescription Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Prescription Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prescription Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Brand Drugs
Generic Drug
Segment by Application
Hospital
Clinic
Other